ORUK Link
Martin Gouldstone
Martin Gouldstone
Martin Gouldstone
Trustee

Martin Gouldstone is Global Senior Vice President, Syneos One and head of Capital Solutions for Syneos Healthcare,  with responsibility for developing and leading Syneos One’s Capital Solution globally.

His 30-year Industry career has spanned research into genetic fingerprinting, clinical research across Pharmaceuticals, Devices and CROs, and lead commercial roles across several platform drug discovery businesses. As well as his scientific and licensing career Martin has spent 7 years in Corporate Finance specialising in M&A, fundraising, disposals and spin-outs. He brings all of this experience to his role at Syneos Health, where he is helping emerging and established biotech and MedTech businesses with funding to advance their products into late-stage clinical development and commercialisation via a virtual Pharma model.